C

Core Scientific, Inc./tx

CORZ Nasdaq Financial Services · Credit Services Dover, DE www.corescientific.com
$20.13
Mkt Cap 6.47B
and Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, …

and Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the Securities Act ) and Section 21E of the Securities Exchange Act of 1934, as amended, (the Exchange Act ). Forward-looking statements may be identified by the use of words such as ability, aim, assume, estimate, plan, possible, project, forecast, goal, opportunity, intend, will, expect, anticipate, believe, enable, seek, target or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, successfully complete construction of its data centers, and source sufficient electrical energy, necessary long lead infrastructure components, supplies and equipment, the advantages and expected growth of the Company and the Company’s ability to source and retain talent. These statements are provided for illustrative purposes only and are based on various assumptions, whether or not identified in this Annual Report on Form 10-K, and on the current expectations of the Company’s management.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$354.7M
FCF TTM
-$471.2M
Running full 6-factor analysis…